Histones: Controlling Tumor Signaling Circuitry

Manoela D Martins1, Rogerio M Castilho2

  • 1Department of Oral Pathology, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.

Journal of Carcinogenesis & Mutagenesis
|September 2, 2014
PubMed

Insights

Epigenetic modifications, like histone acetylation, are key to understanding tumor biology and progression. Research highlights their role in Head and Neck Squamous Cell Carcinoma (HNSCC) and potential therapeutic strategies.

Area of Science:

  • Tumor biology research
  • Epigenetics
  • Molecular oncology

Background:

  • Histone modifications dynamically regulate gene expression without altering DNA sequence.
  • These epigenetic mechanisms involve histone modifiers and associated proteins.
  • Histones and their modifiers are implicated in modulating tumor behavior and cellular phenotype.

Purpose of the Study:

  • To review recent discoveries in chromatin modifications, focusing on histone acetylation.
  • To explore the molecular circuitry governing tumor progression.
  • To consider novel therapeutic approaches based on epigenetic insights and oncogenomic findings in HNSCC.

Main Methods:

  • Review of recent literature on chromatin modifications and histone acetylation.
  • Analysis of oncogenomic findings in Head and Neck Squamous Cell Carcinoma (HNSCC).
  • Integration of Next Generation Sequencing (NGS) data on histone and modifier mutations.

Main Results:

  • Recent discoveries in histone acetylation are advancing cell biology knowledge.
  • Understanding of molecular circuitry in tumor progression is being reshaped by epigenetic insights.
  • Next Generation Sequencing (NGS) studies reveal significant mutations in histones and modifiers in HNSCC.

Conclusions:

  • Epigenetic modifications, particularly histone acetylation, are crucial in tumor biology.
  • Insights into histone modifications offer potential for novel therapeutic strategies in cancer.
  • Oncogenomic analysis of HNSCC highlights the impact of histone and modifier mutations.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.1K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

1.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K